MORGAN STANLEY PLC/CALL/ASTRAZENECA ADR/82.5/0.1/20.12.24 Share Price

Warrant

DE000MB3F262

Market Closed - Bid/Ask 10:21:03 05/06/2024 pm IST After market 12:19:02 am
0.49 EUR +6.52% Intraday chart for MORGAN STANLEY PLC/CALL/ASTRAZENECA ADR/82.5/0.1/20.12.24 0.485 -1.02%
Current month+24.32%
1 month+48.39%
Date Price Change
05/24/05 0.49 +6.52%
04/24/04 0.46 +6.98%
03/24/03 0.43 +16.22%
31/24/31 0.37 +8.82%
30/24/30 0.34 +9.68%

Delayed Quote Börse Stuttgart

Last update June 05, 2024 at 10:21 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ASTRAZENECA PLC
Issuer Morgan Stanley
WKN MB3F26
ISINDE000MB3F262
Date issued 08/02/2023
Strike 82.5 $
Maturity 20/12/2024 (198 Days)
Parity 10 : 1
Emission price 0.38
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.75
Lowest since issue 0.035
Spread 0.01
Spread %2.04%

Company Profile

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
More about the company

Ratings for AstraZeneca PLC

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: AstraZeneca PLC

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
158.6 USD
Average target price
172.9 USD
Spread / Average Target
+9.02%
Consensus